{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:16:33Z","timestamp":1787663793218,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00520-022-07514-4","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T04:07:05Z","timestamp":1672286825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Conversion ratios for opioid switching: a pragmatic study"],"prefix":"10.1007","volume":"31","author":[{"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Adile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Lo","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"7514_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MH van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen MH et al (2016) Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 51:1070\u20131090","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR2","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1200\/JCO.2013.52.5188","volume":"32","author":"RK Portenoy","year":"2014","unstructured":"Portenoy RK, Ahmed E (2014) Principles of opioid use in cancer pain. J Clin Oncol 32:1662\u20131670","journal-title":"J Clin Oncol"},{"key":"7514_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/cancers11040565","volume":"11","author":"S Mercadante","year":"2019","unstructured":"Mercadante S (2019) The patient with difficult cancer pain. Cancers (Basel) 11:565","journal-title":"Cancers (Basel)"},{"key":"7514_CR4","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","volume":"86","author":"S Mercadante","year":"1999","unstructured":"Mercadante S (1999) Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 86:1856\u20131866","journal-title":"Cancer"},{"key":"7514_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.critrevonc.2015.12.011","volume":"99","author":"S Mercadante","year":"2016","unstructured":"Mercadante S, Bruera E (2016) Opioid\u00a0switching in cancer pain: from the beginning to nowadays. E Crit Rev Oncol Hematol 99:241\u20138","journal-title":"E Crit Rev Oncol Hematol"},{"key":"7514_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1177\/0269216311406577","volume":"25","author":"S Mercadante","year":"2011","unstructured":"Mercadante S, Caraceni A (2011) Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med 25:504\u2013559","journal-title":"Palliat Med"},{"key":"7514_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpainsymman.2009.06.001","volume":"38","author":"H Knotkova","year":"2009","unstructured":"Knotkova H, Fine PG, Portenoy RK (2009) Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage 38:426\u2013439","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.21037\/apm.2020.03.05","volume":"9","author":"ML McPherson","year":"2020","unstructured":"McPherson ML (2020) Why equianalgesic tables are only part of the answer to equianalgesia. Ann Palliat Med 9:537\u2013541","journal-title":"Ann Palliat Med"},{"key":"7514_CR9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jpainsymman.2008.05.016","volume":"37","author":"MA Ben\u00edtez-Rosario","year":"2009","unstructured":"Ben\u00edtez-Rosario MA, Salinas-Mart\u00edn A, Aguirre-Jaime A, P\u00e9rez-M\u00e9ndez L, Feria M (2009) Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors. J Pain Symptom Manage 37:1061\u20131068","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR10","doi-asserted-by":"publisher","unstructured":"Reddy A, Sinclair C, Crawford GB et al (2022) Opioid rotation and conversion ratios used by palliative care professionals: an international survey. J Palliat Med 2022 5.\u00a0\u00a0https:\/\/doi.org\/10.1089\/jpm.2022.0266 Online ahead of print","DOI":"10.1089\/jpm.2022.0266"},{"key":"7514_CR11","doi-asserted-by":"publisher","unstructured":"Mercadante S, Lo Cascio A, Adile C, Ferrera P, Casuccio A (2022) Maddalena Opioid\u00a0Switching\u00a0Score (MOSS) in patients with cancer pain. Pain 2022 2.\u00a0\u00a0https:\/\/doi.org\/10.1097\/j.pain.0000000000002669. Online ahead of print","DOI":"10.1097\/j.pain.0000000000002669"},{"key":"7514_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jpainsymman.2007.12.024","volume":"37","author":"S Mercadante","year":"2009","unstructured":"Mercadante S, Ferrera P, Villari P et al (2009) Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage 37:632\u2013641","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.ejca.2011.11.039","volume":"48","author":"S Mercadante","year":"2012","unstructured":"Mercadante S (2012) Stop and go strategy for opioid switching requires flexibility. Eur J Cancer 48:944\u2013945","journal-title":"Eur J Cancer"},{"key":"7514_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","volume":"114","author":"D Bouassirha","year":"2005","unstructured":"Bouassirha D, Attal N, Alchaar H et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29\u201336","journal-title":"Pain"},{"key":"7514_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/bja\/aex175","volume":"119","author":"MR Mulvey","year":"2017","unstructured":"Mulvey MR, Boland EG, Bouhassira D et al (2017) Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles. Br J Anaesth 119:765\u2013774","journal-title":"Br J Anaesth"},{"key":"7514_CR16","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1097\/j.pain.0000000000000721","volume":"157","author":"S Mercadante","year":"2016","unstructured":"Mercadante S, Portenoy RK (2016) Breakthrough cancer pain: twenty-five years of study. Pain 157:2657\u20132663","journal-title":"Pain"},{"key":"7514_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40122-021-00272-x","volume":"10","author":"S Mercadante","year":"2021","unstructured":"Mercadante S, Coluzzi F (2021) Factors influencing pain expression in patients with cancer: an expert opinion. Pain Ther 10:765\u2013775","journal-title":"Pain Ther"},{"key":"7514_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","volume":"53","author":"D Hui","year":"2017","unstructured":"Hui D, Bruera E (2017) The Edmonton Symptom Assessment System 25 years later: past, present, and future developments. J Pain Symptom Manage 53:630\u2013643","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0885-3924(96)00316-8","volume":"13","author":"W Breibart","year":"1997","unstructured":"Breibart W, Rosenfeld B, Roth A et al (1997) The Memorial Delrium Assessment Scale. J Pain Symptom Manage 13:128\u2013137","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0885-3924(01)00294-9","volume":"22","author":"J Pereira","year":"2001","unstructured":"Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E (2001) Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage 22:672\u2013678","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1634\/theoncologist.2012-0269","volume":"18","author":"A Reddy","year":"2013","unstructured":"Reddy A, Yennurajalingam S, Pulivarthi K et al (2013) Frequency, outcome, and predictors of success within 6 weeks of an\u00a0opioid rotation\u00a0among outpatients with cancer receiving strong opioids. Oncologist 18:212\u201320","journal-title":"Oncologist"},{"key":"7514_CR22","first-page":"892","volume":"17","author":"A Rennick","year":"2016","unstructured":"Rennick A, Atkinson T, Cimino NM et al (2016) Variability in opioid equivalence calculations. Pain Med 17:892\u2013898","journal-title":"Pain Med"},{"key":"7514_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","volume":"57","author":"ML McPherson","year":"2019","unstructured":"McPherson ML, Walker K, Davis M et al (2019) Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage 57:635\u2013645","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR24","doi-asserted-by":"crossref","unstructured":"Quigley C (2004) Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev (3): CD004847","DOI":"10.1002\/14651858.CD004847"},{"key":"7514_CR25","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1200\/JCO.1999.17.10.3307","volume":"17","author":"S Mercadante","year":"1999","unstructured":"Mercadante S, Casuccio A, Calderone L (1999) Rapid switching from morphine to methadone in cancer patients with poor response to morphine. J Clin Oncol 17:3307\u20133312","journal-title":"J Clin Oncol"},{"key":"7514_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1526-4637.2012.01334.x","volume":"13","author":"S Mercadante","year":"2012","unstructured":"Mercadante S (2012) Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med 13:399\u2013404","journal-title":"Pain Med"},{"key":"7514_CR27","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1200\/JCO.2005.13.128","volume":"23","author":"S Mercadante","year":"2005","unstructured":"Mercadante S, Ferrera P, Villari P, Casuccio A (2005) Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol 23:5229\u20135234","journal-title":"J Clin Oncol"},{"key":"7514_CR28","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1200\/JCO.2002.20.9.2409","volume":"20","author":"S Watanabe","year":"2002","unstructured":"Watanabe S, Tarumi Y, Oneschuk D, Lawlor P (2002) Opioid rotation to methadone: proceed with caution. J Clin Oncol 20:2409\u20132410","journal-title":"J Clin Oncol"},{"key":"7514_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/00001622-200007000-00006","volume":"12","author":"I Mancini","year":"2000","unstructured":"Mancini I, Lossignol DA, Body JJ (2000) Opioid switch to oral methadone in cancer pain. Curr Opin Oncol 12:308\u2013313","journal-title":"Curr Opin Oncol"},{"key":"7514_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0885-3924(99)00083-4","volume":"18","author":"NA Hagen","year":"1999","unstructured":"Hagen NA, Wasylenko E (1999) Methadone: outpatient titration and monitoring strategies in cancer patients. J Pain Symptom Manage 18:369\u2013375","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/cncr.24754","volume":"116","author":"HA Parsons","year":"2010","unstructured":"Parsons HA, de la Cruz M, El Osta B et al (2010) Methadone initiation and rotation in the outpatient setting for patients with cancer pain. Cancer 116:520\u2013528","journal-title":"Cancer"},{"key":"7514_CR32","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1634\/theoncologist.2015-0503","volume":"21","author":"J Porta-Sales","year":"2016","unstructured":"Porta-Sales J, Garz\u00f3n-Rodr\u00edguez C, Villavicencio-Ch\u00e1vez C, Llorens-Torrom\u00e9 S, Gonz\u00e1lez-Barboteo J (2016) Efficacy and safety of methadone as a second-line\u00a0opioid\u00a0for cancer pain in an outpatient clinic: a prospective open-label study. Oncologist 21:981\u20137","journal-title":"Oncologist"},{"key":"7514_CR33","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1089\/jpm.2007.0285","volume":"11","author":"PW Walker","year":"2008","unstructured":"Walker PW, Palla S, Pei BL et al (2008) Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med 11:1103\u20131108","journal-title":"J Palliat Med"},{"key":"7514_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1634\/theoncologist.2012-0269","volume":"18","author":"A Reddy","year":"2013","unstructured":"Reddy A, Yennurajalingam S, Pulivarthi K et al (2013) Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids. Oncologist 18:212\u2013220","journal-title":"Oncologist"},{"key":"7514_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/jpm.2011.0198","volume":"15","author":"S Mercadante","year":"2012","unstructured":"Mercadante S, Bruera E (2012) The effect of age on opioid switching to methadone: a systematic review. J Palliat Med 15:347\u2013351","journal-title":"J Palliat Med"},{"key":"7514_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0885-3924(99)00049-4","volume":"18","author":"B Gagnon","year":"1999","unstructured":"Gagnon B, Bruera E (1999) Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain. J Pain Symptom Manage 18:120\u2013125","journal-title":"J Pain Symptom Manage"},{"key":"7514_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1089\/jpm.2019.0243","volume":"23","author":"Y Oian","year":"2020","unstructured":"Oian Y, Haider A, Lu Z et al (2020) Factors associated with improvement in uncontrolled cancer pain without increasing the opioid daily dose among patients seen by an inpatient palliative care team. J Palliat Med 23:483\u2013488","journal-title":"J Palliat Med"},{"key":"7514_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1526-4637.2012.01334.x","volume":"13","author":"S Mercadante","year":"2012","unstructured":"Mercadante S (2012) Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med 13:399\u2013404","journal-title":"Pain Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07514-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T04:35:22Z","timestamp":1674016522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07514-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["7514"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07514-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1943917\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"91"}}